Hospitals across the nation are looking for ways to improve outcomes and reduce clinical spend. However, this can be a challenging task if healthcare organizations aren't armed with the right information. To solve this problem, Vanderbilt looked for outside assistance from Chicago-based Procured Health. Procured offers a medical product research platform that allows users to compare devices. Through comparison, hospitals can determine if a higher price product is worth the extra cost, or if similar outcomes can be achieved using a less expensive product.
Read MoreOne Medical Passport, Inc., a leading provider of cloud-based peri-operative medical software, announced today that it has closed a $4 million Series A investment from FCA Venture Partners, a Nashville-based venture capital firm focused on healthcare IT. One Medical Passport’s online software is used by over two million patients and 700 medical facilities annually throughout the U.S., and its customers include many of the top healthcare management companies.
Read MoreEntrada and Clinical Ink, were named to the 2015 Inc.5000 Fastest Growing Companies list, an exclusive ranking of the nation’s fastest growing private companies.
Read MoreThe Agreement means Stanford's medical staff and patient care teams will incorporate Procured Health's IntelligencePro™ and EvaluationPro™ solutions into their product evaluation and selection processes.
Read MoreFCA V Portfolio Company, ChartWise Medical Systems, Inc., was selected a Red Herring Top 100 North America Winner. This award recognizes ChartWise as one of the technology industry’s top private companies.
The Red Herring Top 100 North America winners represent outstanding entrepreneurs and promising companies. Award winners are chosen from approximately 1,200 privately financed companies each year in the US and Canada. A review of the track record and standing of startups relative to their sector peers, allowed Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America, complement this assessment of potential.
Read MoreClinical Ink, the pioneering provider of eSource solutions for clinical trials, today announced a merger with CentrosHealth, the ground-breaking provider of configurable mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO) founded by MPM Capital. The company also announced that MPM Capital and F2 Ventures joined FCA Venture Partners and other existing investors to provide additional growth capital for Clinical Ink to aggressively expand operational capabilities and further development of the first truly paperless clinical trial platform. Clinical Ink additionally entered into a strategic partnership with Novartis Pharmaceuticals, as part of their Trials of the Future initiative, to help drive industry-wide adoption of fully electronic clinical trials.
Read MoreThe Wistar Institute, an international leader in biomedical research, and Kerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced Wistar’s partnership in the Kerafast Fellows Program. The program aims to provide scientists with real-life experiences in the technology commercialization field, an exciting, dynamic and increasingly competitive discipline.
Read More